Massive Soft Tissue Neurofibroma (Elephantiasis Neuromatosa): Case Report and Review of Literature.

Abstract

The authors review the literature on massive soft tissue neurofibroma. The methods included a review of 71 reports (PubMed search 1929-2012) with a total of 91 massive soft tissue neurofibroma patients and illustration of clinical and radiological progression of massive soft tissue neurofibroma on a patient with neurofibromatosis type 1. The mean age at initial examination was 21 years. Tumor onset was mostly in childhood years. The commonest affected body segment was the lower extremity (46%), followed by head/neck (30%). Surgical management was pursued in the majority of cases (79%). Bleeding was a common complication (25%). Recurrence was described in 12%; multiple resections cases were described. Malignant transformation occurred in 5%. Although massive soft tissue neurofibroma may be present early in life, massive tumor overgrowth may take years. Predicting disease progression and/or benefit of surgical intervention early in the disease course is challenging. Recurrence and malignant transformation are possible. Massive soft tissue neurofibroma does not respond to chemotherapy or radiotherapy and is associated with life-threatening surgical complications.

• Authors: Fernando Santos Pinheiro, A David Rothner, Manikum Moodley, Kenneth G Zahka
• Journal: Journal of child neurology (J Child Neurol) Vol. 30 Issue 11 Pg. 1537-43 (Oct 2015) ISSN: 1708-8283 [Electronic] United States
• PMID: 25694465 (Publication Type: Case Reports, Journal Article, Review)
• Copyright: © The Author(s) 2015.

Topics

• Adult
• Humans
• Male
• Neurofibroma (genetics, pathology, physiopathology, therapy)
• Soft Tissue Neoplasms (genetics, pathology, physiopathology, therapy)